BioLineRx

BLRX

BioLineRx (Hebrew: ביוליין אר אקס), or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange.

BioLineRx has been a target of short sellers for a while. The current short interest of 2.80% is roughly at the average of the last 12 months (3.37%).